Biovica’s CFO will leave in December 2022

2022-06-30 17:45

Biovica, active in cancer diagnostics, today announces that the company’s CFO and deputy CEO Cecilia Driving today has submitted her letter of resignation. A process to recruit a replacement is immediately initiated. Cecilia Driving, who has been Biovica's CFO since 2016, will continue in her current role until December 31, 2022.

“During her time as CFO and deputy CEO, Cecilia has been very important for the company's development. From the time we presented our first clinical results until today, when we are on the threshold of launching DiviTum®TKa on the US market. I want to thank Cecilia for good cooperation and for valuable contributions to the company's exceptional development during her time and wish her the best of luck in the future", said Anders Rylander, CEO of Biovica.

“Biovica is facing an exciting time when DiviTum®TKa will be launched for the benefit of cancer patients and caregivers. This has been one of the most fun and interesting jobs I have ever had, and I am grateful to have been part of this important and exciting business. It has not been an easy decision to leave such a stimulating environment, and a fantastic team", said Cecilia Driving.


Numbers of patients in studies




Pharma Projects

Are you a US resident?

Only US residents will be able to qualify for this program